137 related articles for article (PubMed ID: 2198415)
21. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
Mendis S; Somasiri KG; Chularatna W
Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
[TBL] [Abstract][Full Text] [Related]
22. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
Sehgal VN; Kumar S; Jain S; Bhattacharya SN
J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
[No Abstract] [Full Text] [Related]
23. Distinguishing between relapse and late reversal reaction in multidrug (MDT)-treated BT leprosy.
Waters MF
Lepr Rev; 2001 Sep; 72(3):250-3. PubMed ID: 11715270
[No Abstract] [Full Text] [Related]
24. Borderline tuberculoid leprosy developing in a pure neuritic case.
Porichha D; Mahapatra DC
Indian J Lepr; 1991; 63(2):235-7. PubMed ID: 1783794
[No Abstract] [Full Text] [Related]
25. Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
Pritze S; Alvarenga AE; Leguizamon O; Haubitz I
Chemotherapy; 1989; 35(5):373-82. PubMed ID: 2676405
[TBL] [Abstract][Full Text] [Related]
26. Twelve months fixed duration WHO multidrug therapy for multibacillary leprosy: incidence of relapses in Agra field based cohort study.
Kumar A; Girdhar A; Girdhar BK
Indian J Med Res; 2013 Oct; 138(4):536-40. PubMed ID: 24434261
[TBL] [Abstract][Full Text] [Related]
27. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
Thomas A; Hari L; Nagarajan M; Prabhakar R
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
[TBL] [Abstract][Full Text] [Related]
28. Study of multidrug therapy in paucibacillary leprosy.
Kar PK; Sohi AS
J Indian Med Assoc; 1989 Feb; 87(2):34-6. PubMed ID: 2674283
[TBL] [Abstract][Full Text] [Related]
29. Oral lesion in leprosy: borderline tuberculoid diagnosis based on detection of Mycobacterium leprae DNA by qPCR.
da Silva Martinez T; Nahas AA; Figueira MM; Costa AV; Gonçalves MA; Goulart LR; Goulart IM
Acta Derm Venereol; 2011 Oct; 91(6):704-7. PubMed ID: 21879249
[TBL] [Abstract][Full Text] [Related]
30. Clinical and histopathological activity in paucibacillary leprosy patients after fixed-duration multidrug therapy.
Ebenezer GJ; Suneetha S; Arunthathi S
Lepr Rev; 1997 Sep; 68(3):218-24. PubMed ID: 9364822
[TBL] [Abstract][Full Text] [Related]
31. Relapse in leprosy after multidrug therapy and its differential diagnosis with reversal reaction.
Reddy PK; Cherian A
Indian J Lepr; 1991; 63(1):61-9. PubMed ID: 1919091
[TBL] [Abstract][Full Text] [Related]
32. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens. Marchoux Chemotherapy Study Group.
Jamet P; Ji B
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):525-35. PubMed ID: 1299707
[TBL] [Abstract][Full Text] [Related]
33. Relapse rate in paucibacillary leprosy patients after multidrug therapy in North Arcot District.
Ekambaram V; Rao MK
Indian J Lepr; 1991; 63(1):34-42. PubMed ID: 1919088
[TBL] [Abstract][Full Text] [Related]
34. Leprosy in a preschool child--a case report.
Arora SK
J Indian Med Assoc; 2007 Mar; 105(3):140. PubMed ID: 17824468
[TBL] [Abstract][Full Text] [Related]
35. A case of relapse with drug-susceptible M. leprae after multidrug therapy.
Constant-Desportes M; Guelpa-Lauras CC; Carolina JC; Léoture A; Grosset JH; Sansarricq H
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):242-7. PubMed ID: 2071981
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of five treatment regimens, using either dapsone monotherapy or several doses of rifampicin in the treatment of paucibacillary leprosy.
Pattyn SR; Husser JA; Baquillon G; Maiga M; Jamet P
Lepr Rev; 1990 Jun; 61(2):151-6. PubMed ID: 2198414
[TBL] [Abstract][Full Text] [Related]
37. Bacillaemia in leprosy and effect of multidrug therapy.
Chatterjee G; Kaur S; Sharma VK; Vaishnavi C; Ganguly NK
Lepr Rev; 1989 Sep; 60(3):197-201. PubMed ID: 2682105
[TBL] [Abstract][Full Text] [Related]
38. Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):292-303. PubMed ID: 2071986
[TBL] [Abstract][Full Text] [Related]
39. Treatment of paucibacillary leprosy with a regimen containing rifampicin, dapsone and prothionamide.
Katoch K; Natarajan M; Bhatia AS; Yadav VS
Indian J Lepr; 1992; 64(3):303-12. PubMed ID: 1431319
[TBL] [Abstract][Full Text] [Related]
40. Facial tuberculoid leprosy: case report.
Ali K; Sittampalam G; Malik MA
Br J Oral Maxillofac Surg; 2011 Jan; 49(1):70-2. PubMed ID: 20188445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
